Status:
COMPLETED
ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan for Patients Infected With COVID-19
Lead Sponsor:
Prof. Dr. Sonia Lippke
Collaborating Sponsors:
Dr. Becker Hospital Group
Dr. Becker Kiliani Clinic
Conditions:
Long-COVID
Post-COVID
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Post-/long-COVID occurs in patients with severe, moderate, and even mild courses. The symptomatology is multi-layered and complex. Patients with mild and moderate courses and especially younger patien...
Detailed Description
The goal is the long-term and sustainable holistic treatment and support of patients with post-/long-COVID to prevent long-term illness and chronification. Following the earliest possible, low-thresho...
Eligibility Criteria
Inclusion
- All people who are resident in Bavaria can participate in the intervention and control group. In the comparison group all people who live and work in Germany can take part
- working age
- ability to participate in surveys (e.g., sufficient German language skills)
- willingness to participate in outpatient or (partially) inpatient therapy
- ability to undergo rehabilitation if necessary, and a telephone and Internet connection
- suspicion of post-/long-COVID
Exclusion
- Contraindications regarding physical exercise,
- not being of age,
- illiteracy
- massively limited cognitive abilities (linguistic components of the digital offerings must be able to be used and questionnaires completed or interviews participated in)
Key Trial Info
Start Date :
December 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT05238415
Start Date
December 15 2021
End Date
June 30 2023
Last Update
August 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Becker Klinikgruppe
Cologne, Germany, 50968